AQR Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $398K | Buy |
231,657
+172,117
| +289% | +$296K | ﹤0.01% | 2726 |
|
2025
Q1 | $195K | Buy |
59,540
+43,829
| +279% | +$144K | ﹤0.01% | 2896 |
|
2024
Q4 | $114K | Buy |
+15,711
| New | +$114K | ﹤0.01% | 2755 |
|
2024
Q3 | – | Sell |
-11,477
| Closed | -$92K | – | 2823 |
|
2024
Q2 | $92K | Sell |
11,477
-28,534
| -71% | -$229K | ﹤0.01% | 2501 |
|
2024
Q1 | $583K | Buy |
+40,011
| New | +$583K | ﹤0.01% | 1908 |
|
2023
Q2 | – | Sell |
-84,325
| Closed | -$515K | – | 2234 |
|
2023
Q1 | $515K | Buy |
84,325
+34,576
| +70% | +$211K | ﹤0.01% | 1771 |
|
2022
Q4 | $308K | Buy |
+49,749
| New | +$308K | ﹤0.01% | 1963 |
|
2021
Q2 | – | Sell |
-34,022
| Closed | -$1.06M | – | 2262 |
|
2021
Q1 | $1.06M | Sell |
34,022
-5,077
| -13% | -$158K | ﹤0.01% | 1525 |
|
2020
Q4 | $1.81M | Buy |
39,099
+8,689
| +29% | +$403K | ﹤0.01% | 1214 |
|
2020
Q3 | $987K | Sell |
30,410
-79,292
| -72% | -$2.57M | ﹤0.01% | 1407 |
|
2020
Q2 | $3.01M | Buy |
109,702
+42,489
| +63% | +$1.17M | ﹤0.01% | 979 |
|
2020
Q1 | $2.01M | Buy |
67,213
+24,361
| +57% | +$729K | ﹤0.01% | 1069 |
|
2019
Q4 | $1.19M | Buy |
42,852
+17,655
| +70% | +$489K | ﹤0.01% | 1456 |
|
2019
Q3 | $459K | Buy |
+25,197
| New | +$459K | ﹤0.01% | 1780 |
|
2019
Q1 | – | Sell |
-33,573
| Closed | -$297K | – | 2185 |
|
2018
Q4 | $297K | Sell |
33,573
-13,119
| -28% | -$116K | ﹤0.01% | 1965 |
|
2018
Q3 | $525K | Buy |
46,692
+7,293
| +19% | +$82K | ﹤0.01% | 1941 |
|
2018
Q2 | $504K | Buy |
+39,399
| New | +$504K | ﹤0.01% | 1976 |
|
2016
Q4 | – | Sell |
-14,630
| Closed | -$120K | – | 2259 |
|
2016
Q3 | $120K | Hold |
14,630
| – | – | ﹤0.01% | 2215 |
|
2016
Q2 | $119K | Sell |
14,630
-7,648
| -34% | -$62.2K | ﹤0.01% | 2156 |
|
2016
Q1 | $113K | Hold |
22,278
| – | – | ﹤0.01% | 2180 |
|
2015
Q4 | $172K | Sell |
22,278
-12,944
| -37% | -$99.9K | ﹤0.01% | 2176 |
|
2015
Q3 | $203K | Buy |
35,222
+4,454
| +14% | +$25.7K | ﹤0.01% | 2058 |
|
2015
Q2 | $282K | Buy |
+30,768
| New | +$282K | ﹤0.01% | 2009 |
|